Update on the review of CEP applications for sartans

2018-12-20 10:36:49.0

Followingnew information received recently about the presence of nitrosamine impuritiesin drug substances covered by certificates of suitability (CEPs), the EDQM hastaken immediate actions on CEPs until appropriate corrective actions areimplemented by the relevant companies: